Nifty

:

26046.95

Sensex

:

85267.66

148.40 (0.57%)
449.53 (0.53%)

Login

Nifty
Sensex

:
:

26046.95
85267.66

148.40 (0.57%)
449.53 (0.53%)

Indoco Remedies Ltd.

Pharmaceuticals & Drugs - Global

Rating :

42/99

BSE: 532612 | NSE: INDOCO

Watchlist

NSE BSE

242.55

12-Dec-2025

Open
High
Low
Previous Close

245
250.85
238.95
239.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

103126
25189118.6
349.8
190

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,241.62
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,160.28
0.08%
2.29

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.14
6.04
-0.07

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-5.12
-14.59
-19.08

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

28.18
25.43
22.90

P:BV (Average)

8 Years
5 Years
3 Years

3.18
3.38
2.82

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.89
17.63
19.98

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 442.12 396.53 11.50% 392.53 401.43 -2.22% 347.25 445.49 -22.05% 372.98 449.05 -16.94%
Expenses 388.73 343.66 13.11% 377.70 349.86 7.96% 343.79 388.13 -11.42% 352.84 383.76 -8.06%
EBITDA 53.39 52.87 0.98% 14.83 51.57 -71.24% 3.46 57.36 -93.97% 20.14 65.29 -69.15%
EBIDTM 12.08% 13.33% 3.78% 12.85% 1.00% 12.88% 5.40% 14.54%
Other Income 6.54 4.20 55.71% 5.58 3.52 58.52% 6.50 4.05 60.49% 4.26 2.93 45.39%
Interest 22.01 14.77 49.02% 23.61 11.88 98.74% 15.98 10.91 46.47% 14.00 10.03 39.58%
Depreciation 27.63 24.92 10.87% 25.20 23.70 6.33% 24.88 23.73 4.85% 24.75 22.97 7.75%
PBT 9.76 17.38 -43.84% -28.40 19.51 - -30.90 46.50 - -13.36 27.02 -
Tax -5.29 4.59 - -0.34 4.56 - -4.66 8.94 - -3.13 7.01 -
PAT 15.05 12.79 17.67% -28.06 14.95 - -26.24 37.56 - -10.23 20.01 -
PATM 3.40% 3.23% -7.15% 3.72% -7.56% 8.43% -2.74% 4.46%
EPS 1.63 1.39 17.27% -3.04 1.62 - -2.85 4.07 - -1.11 2.17 -

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 484.67 432.66 12.02% 437.89 431.49 1.48% 390.21 449.64 -13.22% 410.55 459.42 -10.64%
Expenses 441.62 392.41 12.54% 420.36 383.72 9.55% 390.99 400.77 -2.44% 398.52 396.52 0.50%
EBITDA 43.05 40.25 6.96% 17.53 47.77 -63.30% -0.78 48.87 - 12.03 62.90 -80.87%
EBIDTM 8.88% 9.30% 4.00% 11.07% -0.20% 10.87% 2.93% 13.69%
Other Income 0.76 1.56 -51.28% 1.63 1.03 58.25% 2.02 2.66 -24.06% 0.85 2.35 -63.83%
Interest 24.56 17.83 37.75% 26.12 14.31 82.53% 17.98 12.05 49.21% 16.11 10.07 59.98%
Depreciation 32.25 28.82 11.90% 29.70 27.52 7.92% 28.78 26.23 9.72% 28.72 24.35 17.95%
PBT -13.53 -4.84 - -36.66 6.97 - -45.52 32.98 - -30.96 22.63 -
Tax -4.32 5.17 - -0.31 5.15 - -4.18 10.95 - -2.56 7.07 -
PAT -9.21 -10.01 - -36.35 1.82 - -41.34 22.03 - -28.40 15.56 -
PATM -1.90% -2.31% -8.30% 0.42% -10.59% 4.90% -6.92% 3.39%
EPS -0.86 -1.04 - -3.88 0.29 - -4.38 2.46 - -2.86 1.77 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,554.88 1,518.19 1,790.81 1,666.69 1,539.72 1,240.30 1,105.99 967.73 1,038.21 1,072.06 1,004.76 Net Sales Growth -8.13% -15.22% 7.45% 8.25% 24.14% 12.14% 14.29% -6.79% -3.16% 6.70% Cost Of Goods Sold 444.13 443.68 546.45 521.29 456.75 354.07 330.43 320.17 346.03 359.60 347.97 Gross Profit 1,110.75 1,074.50 1,244.35 1,145.40 1,082.97 886.24 775.57 647.56 692.18 712.46 656.79 GP Margin 71.44% 70.78% 69.49% 68.72% 70.34% 71.45% 70.12% 66.92% 66.67% 66.46% 65.37% Total Expenditure 1,463.06 1,390.16 1,540.71 1,381.85 1,213.81 1,022.67 985.01 891.03 906.73 917.40 836.83 Power & Fuel Cost - 53.45 55.31 50.61 42.78 36.89 34.75 28.49 26.62 23.12 21.72 % Of Sales - 3.52% 3.09% 3.04% 2.78% 2.97% 3.14% 2.94% 2.56% 2.16% 2.16% Employee Cost - 368.74 350.55 321.15 294.95 272.88 255.32 231.26 220.34 216.05 181.41 % Of Sales - 24.29% 19.57% 19.27% 19.16% 22.00% 23.09% 23.90% 21.22% 20.15% 18.06% Manufacturing Exp. - 193.68 244.20 195.91 184.62 130.30 114.61 106.86 101.47 96.11 84.80 % Of Sales - 12.76% 13.64% 11.75% 11.99% 10.51% 10.36% 11.04% 9.77% 8.96% 8.44% General & Admin Exp. - 137.13 132.67 122.71 107.50 98.28 128.33 110.90 109.03 116.21 102.31 % Of Sales - 9.03% 7.41% 7.36% 6.98% 7.92% 11.60% 11.46% 10.50% 10.84% 10.18% Selling & Distn. Exp. - 148.28 146.97 111.33 83.19 76.02 89.28 62.75 70.53 73.22 55.89 % Of Sales - 9.77% 8.21% 6.68% 5.40% 6.13% 8.07% 6.48% 6.79% 6.83% 5.56% Miscellaneous Exp. - 45.19 64.55 58.84 44.02 54.23 32.31 30.58 32.70 33.09 55.89 % Of Sales - 2.98% 3.60% 3.53% 2.86% 4.37% 2.92% 3.16% 3.15% 3.09% 4.25% EBITDA 91.82 128.03 250.10 284.84 325.91 217.63 120.98 76.70 131.48 154.66 167.93 EBITDA Margin 5.91% 8.43% 13.97% 17.09% 21.17% 17.55% 10.94% 7.93% 12.66% 14.43% 16.71% Other Income 22.88 18.48 17.38 2.62 6.71 9.05 4.79 6.71 8.15 6.10 4.14 Interest 75.60 56.63 37.80 25.27 17.43 22.22 26.25 21.09 23.51 6.16 12.15 Depreciation 102.46 98.25 87.98 70.60 78.95 73.12 70.81 71.56 67.71 63.27 60.63 PBT -62.90 -8.37 141.70 191.59 236.23 131.35 28.71 -9.24 48.43 91.34 99.29 Tax -13.42 1.36 36.58 50.23 81.71 38.96 4.46 -6.40 7.23 13.88 17.00 Tax Rate 21.34% -18.43% 23.87% 26.22% 34.59% 29.66% 15.53% 69.26% 14.93% 15.20% 17.12% PAT -49.48 -8.73 116.64 141.36 154.52 92.39 24.25 -2.84 41.20 77.46 82.29 PAT before Minority Interest -49.48 -8.73 116.64 141.36 154.52 92.39 24.25 -2.84 41.20 77.46 82.29 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -3.18% -0.58% 6.51% 8.48% 10.04% 7.45% 2.19% -0.29% 3.97% 7.23% 8.19% PAT Growth -158.00% - -17.49% -8.52% 67.25% 280.99% - - -46.81% -5.87% EPS -5.37 -0.95 12.65 15.33 16.76 10.02 2.63 -0.31 4.47 8.40 8.93

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,723.32 1,664.92 1,817.29 1,668.61 1,540.75 1,241.53 1,106.58 968.45 1,041.94 1,074.77 1,008.12 Net Sales Growth -2.81% -8.38% 8.91% 8.30% 24.10% 12.20% 14.26% -7.05% -3.05% 6.61% Cost Of Goods Sold 500.20 498.18 559.18 521.29 456.79 354.10 330.43 320.25 347.83 361.27 350.01 Gross Profit 1,223.12 1,166.73 1,258.10 1,147.32 1,083.97 887.42 776.15 648.19 694.11 713.49 658.12 GP Margin 70.97% 70.08% 69.23% 68.76% 70.35% 71.48% 70.14% 66.93% 66.62% 66.39% 65.28% Total Expenditure 1,651.49 1,565.67 1,580.87 1,382.57 1,214.50 1,023.20 985.74 891.80 910.37 920.27 840.17 Power & Fuel Cost - 59.61 56.00 50.61 42.78 36.89 34.75 28.49 26.62 23.12 21.72 % Of Sales - 3.58% 3.08% 3.03% 2.78% 2.97% 3.14% 2.94% 2.55% 2.15% 2.15% Employee Cost - 394.05 361.93 322.58 296.28 274.02 256.51 231.66 220.91 216.67 181.87 % Of Sales - 23.67% 19.92% 19.33% 19.23% 22.07% 23.18% 23.92% 21.20% 20.16% 18.04% Manufacturing Exp. - 214.28 247.42 195.91 184.62 130.32 114.63 107.07 101.94 96.38 85.18 % Of Sales - 12.87% 13.61% 11.74% 11.98% 10.50% 10.36% 11.06% 9.78% 8.97% 8.45% General & Admin Exp. - 152.02 137.54 121.88 106.75 97.57 127.76 110.92 110.04 116.40 102.56 % Of Sales - 9.13% 7.57% 7.30% 6.93% 7.86% 11.55% 11.45% 10.56% 10.83% 10.17% Selling & Distn. Exp. - 189.69 149.45 111.33 83.19 76.02 89.28 62.75 70.53 73.22 55.89 % Of Sales - 11.39% 8.22% 6.67% 5.40% 6.12% 8.07% 6.48% 6.77% 6.81% 5.54% Miscellaneous Exp. - 57.83 69.34 58.95 44.10 54.28 32.38 30.66 32.49 33.20 55.89 % Of Sales - 3.47% 3.82% 3.53% 2.86% 4.37% 2.93% 3.17% 3.12% 3.09% 4.26% EBITDA 71.83 99.25 236.42 286.04 326.25 218.33 120.84 76.65 131.57 154.50 167.95 EBITDA Margin 4.17% 5.96% 13.01% 17.14% 21.17% 17.59% 10.92% 7.91% 12.63% 14.38% 16.66% Other Income 5.26 5.45 18.72 2.63 3.42 9.06 4.80 6.70 8.05 5.93 4.03 Interest 84.77 66.23 39.01 25.27 14.14 22.26 26.25 21.09 23.51 6.21 12.39 Depreciation 119.45 113.84 91.87 70.61 78.96 73.13 70.82 71.57 67.71 63.28 60.66 PBT -126.67 -75.36 124.27 192.79 236.57 132.00 28.57 -9.31 48.40 90.94 98.93 Tax -11.37 3.58 38.79 50.54 81.77 38.95 4.45 -6.41 7.24 13.87 16.99 Tax Rate 8.98% -4.81% 28.56% 26.22% 34.56% 29.51% 15.58% 68.85% 14.96% 15.25% 17.17% PAT -115.30 -73.74 98.46 142.25 154.80 93.05 24.12 -2.90 41.16 77.06 81.94 PAT before Minority Interest -110.50 -77.95 97.00 142.25 154.80 93.05 24.12 -2.90 41.16 77.06 81.94 Minority Interest 4.80 4.21 1.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -6.69% -4.43% 5.42% 8.53% 10.05% 7.49% 2.18% -0.30% 3.95% 7.17% 8.13% PAT Growth -492.18% - -30.78% -8.11% 66.36% 285.78% - - -46.59% -5.96% EPS -12.51 -8.00 10.68 15.43 16.79 10.09 2.62 -0.31 4.46 8.36 8.89

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,103.36 1,126.62 1,027.02 904.30 768.93 680.16 661.08 675.56 651.88 576.45 Share Capital 18.45 18.44 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 Total Reserves 1,079.17 1,104.64 1,007.93 885.87 750.50 661.73 642.65 657.13 633.45 558.02 Non-Current Liabilities 402.79 271.74 205.41 156.57 158.29 100.91 116.34 125.27 146.97 66.33 Secured Loans 336.89 203.60 143.50 95.88 96.94 96.93 128.66 123.28 132.31 34.24 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.64 Long Term Provisions 34.88 33.47 33.33 31.64 66.20 27.08 15.91 23.74 30.87 40.72 Current Liabilities 695.01 595.03 483.21 519.93 408.54 459.17 445.33 416.89 390.37 301.77 Trade Payables 147.38 118.97 126.45 135.32 115.02 166.29 170.70 149.44 164.17 131.01 Other Current Liabilities 169.16 144.66 131.88 139.46 129.33 135.35 117.02 119.32 72.07 57.30 Short Term Borrowings 333.40 250.35 119.45 103.73 117.31 105.98 113.39 109.93 118.36 86.47 Short Term Provisions 45.07 81.05 105.43 141.41 46.88 51.55 44.21 38.19 35.77 26.99 Total Liabilities 2,201.16 1,993.39 1,715.64 1,580.80 1,335.76 1,240.24 1,222.75 1,217.72 1,189.22 944.55 Net Block 754.38 732.34 661.46 554.98 569.91 589.62 467.52 488.73 439.75 373.26 Gross Block 1,665.59 1,554.80 1,406.09 1,236.03 1,177.68 1,126.60 934.50 884.96 769.49 641.58 Accumulated Depreciation 911.21 822.46 744.63 681.05 607.76 536.99 466.98 396.23 329.74 268.32 Non Current Assets 1,245.69 1,060.39 847.21 714.79 713.81 678.48 686.25 680.57 619.04 483.08 Capital Work in Progress 225.78 114.44 112.57 121.53 68.10 50.70 185.43 135.56 90.63 54.80 Non Current Investment 51.96 51.96 18.90 2.46 2.45 2.45 2.44 2.61 2.82 2.61 Long Term Loans & Adv. 207.26 154.87 52.03 25.98 63.95 26.07 21.75 33.58 66.34 48.02 Other Non Current Assets 6.30 6.78 2.25 9.83 9.39 9.64 9.11 20.09 19.51 4.39 Current Assets 955.47 932.99 868.44 866.01 621.95 561.76 536.50 537.15 570.18 461.46 Current Investments 0.00 7.24 1.00 0.00 0.00 0.00 0.00 0.00 0.00 15.68 Inventories 362.86 310.42 325.99 310.52 237.81 208.24 183.37 193.23 185.04 164.47 Sundry Debtors 374.05 408.02 350.82 297.00 233.58 209.18 194.47 207.83 215.73 187.72 Cash & Bank 12.03 16.94 12.40 19.21 14.05 37.65 36.18 11.81 62.40 12.44 Other Current Assets 206.52 59.63 20.17 34.59 136.50 106.70 122.48 124.28 107.01 81.15 Short Term Loans & Adv. 133.62 130.73 158.06 204.70 124.61 97.59 106.94 117.83 89.38 72.50 Net Current Assets 260.46 337.96 385.23 346.08 213.41 102.59 91.17 120.27 179.81 159.70 Total Assets 2,201.16 1,993.38 1,715.65 1,580.80 1,335.76 1,240.24 1,222.75 1,217.72 1,189.22 944.54

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,022.00 1,109.90 1,028.25 904.64 768.99 679.57 660.62 674.98 651.34 576.52 Share Capital 18.45 18.44 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 Total Reserves 997.81 1,087.93 1,009.16 886.21 750.56 661.14 642.19 656.55 632.91 558.08 Non-Current Liabilities 603.54 421.90 205.44 156.60 158.36 101.00 116.42 125.34 147.04 66.28 Secured Loans 533.20 351.73 143.50 95.88 96.94 96.93 128.66 123.28 132.31 34.24 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.64 Long Term Provisions 35.82 33.68 33.40 31.74 66.35 27.14 15.95 23.77 30.91 40.63 Current Liabilities 808.47 645.50 480.79 518.16 406.92 458.99 445.50 417.36 390.39 302.95 Trade Payables 208.13 153.64 123.46 133.29 113.23 165.60 170.72 149.55 164.03 131.31 Other Current Liabilities 192.71 149.80 132.06 139.61 129.48 135.81 117.13 119.66 72.16 57.38 Short Term Borrowings 362.01 260.52 119.45 103.73 117.31 105.98 113.39 109.93 118.36 87.23 Short Term Provisions 45.62 81.53 105.82 141.53 46.91 51.59 44.26 38.22 35.84 27.03 Total Liabilities 2,430.39 2,177.90 1,714.48 1,579.40 1,334.27 1,239.56 1,222.54 1,217.68 1,188.77 945.75 Net Block 996.88 954.29 678.25 555.10 569.94 589.74 467.65 488.86 439.89 373.64 Gross Block 1,927.60 1,780.68 1,422.93 1,236.19 1,177.74 1,126.76 934.65 885.11 769.65 641.95 Accumulated Depreciation 930.72 826.39 744.68 681.09 607.80 537.02 467.00 396.25 329.75 268.32 Non Current Assets 1,428.58 1,190.06 844.63 712.47 711.75 676.45 684.49 678.73 616.72 481.20 Capital Work in Progress 320.54 124.81 113.60 121.53 68.19 50.70 185.43 135.56 90.63 54.80 Non Current Investment 1.46 1.46 1.46 0.02 0.02 0.02 0.02 0.02 0.02 0.02 Long Term Loans & Adv. 102.75 102.45 49.06 25.99 64.01 26.16 22.01 33.92 66.46 48.15 Other Non Current Assets 6.94 7.04 2.26 9.83 9.59 9.83 9.38 20.36 19.72 4.60 Current Assets 1,001.81 987.84 869.85 866.92 622.53 563.10 538.05 538.96 572.05 464.55 Current Investments 0.00 7.24 1.00 0.00 0.00 0.00 0.00 0.00 0.00 15.68 Inventories 419.35 353.06 325.99 310.52 237.85 208.32 183.45 193.38 186.94 166.69 Sundry Debtors 352.41 406.20 350.94 297.25 233.82 210.14 195.84 209.51 215.68 188.83 Cash & Bank 17.07 24.32 13.34 19.77 14.34 37.93 36.26 11.90 62.59 12.63 Other Current Assets 212.98 42.23 20.18 34.59 136.52 106.71 122.51 124.17 106.85 80.72 Short Term Loans & Adv. 167.48 154.78 158.41 204.80 124.62 97.60 106.96 117.71 89.21 72.06 Net Current Assets 193.34 342.34 389.06 348.77 215.61 104.12 92.55 121.60 181.66 161.60 Total Assets 2,430.39 2,177.90 1,714.48 1,579.39 1,334.28 1,239.55 1,222.54 1,217.69 1,188.77 945.75

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 90.77 176.78 178.79 173.55 82.17 122.66 132.13 122.76 87.81 112.31 PBT -8.37 141.70 191.59 236.23 131.35 28.71 -9.24 48.43 91.34 99.29 Adjustment 147.22 130.08 120.88 87.12 109.71 99.51 89.34 97.82 64.31 78.78 Changes in Working Capital -32.49 -77.42 -72.29 -108.81 -139.14 -1.65 55.66 -13.59 -44.07 -38.46 Cash after chg. in Working capital 106.37 194.36 240.18 214.54 101.92 126.57 135.75 132.65 111.57 139.61 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -16.60 -29.10 -61.38 -40.99 -19.75 -3.92 -3.62 -9.89 -23.77 -27.31 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.99 11.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -259.79 -301.70 -208.51 -121.41 -66.70 -55.95 -103.76 -135.43 -170.54 -112.62 Net Fixed Assets -222.13 -150.58 -161.10 -111.78 -68.48 -57.37 -99.41 -160.40 -163.74 -86.39 Net Investments 7.24 -39.30 -17.44 -0.01 0.00 -0.01 0.17 0.21 15.47 -17.65 Others -44.90 -111.82 -29.97 -9.62 1.78 1.43 -4.52 24.76 -22.27 -8.58 Cash from Financing Activity 168.62 122.40 22.81 -44.37 -29.83 -63.95 -16.14 -38.77 132.40 0.17 Net Cash Inflow / Outflow -0.41 -2.52 -6.91 7.77 -14.35 2.76 12.23 -51.44 49.67 -0.15 Opening Cash & Equivalents 7.47 9.99 16.90 9.13 23.48 20.72 8.48 59.92 10.25 10.40 Closing Cash & Equivalent 7.06 7.47 9.99 16.90 9.13 23.48 20.72 8.48 59.92 10.25

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 94.93 155.39 178.83 173.83 82.22 122.85 132.11 122.72 88.64 113.34 PBT -75.36 124.27 192.79 236.57 132.00 28.57 -9.31 48.40 90.94 100.58 Adjustment 183.64 137.55 120.88 87.12 109.76 99.51 89.35 97.67 64.60 76.29 Changes in Working Capital 2.78 -88.47 -73.19 -108.79 -139.81 -1.49 55.62 -13.23 -43.25 -36.12 Cash after chg. in Working capital 111.06 173.35 240.48 214.91 101.94 126.60 135.66 132.83 112.29 140.75 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -17.12 -29.49 -61.65 -41.08 -19.72 -3.75 -3.55 -10.12 -23.65 -27.41 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.99 11.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -339.11 -432.52 -208.17 -121.41 -66.69 -55.93 -103.76 -135.43 -170.55 -111.96 Net Fixed Assets -222.13 -150.58 -161.10 -111.78 -68.48 -57.37 -99.41 -160.40 -163.74 -86.39 Net Investments 7.24 -39.30 -17.44 -0.01 0.00 -0.01 0.17 0.21 15.47 -17.65 Others -124.22 -242.64 -29.63 -9.62 1.79 1.45 -4.52 24.76 -22.28 -7.92 Cash from Financing Activity 241.42 280.43 22.80 -44.37 -29.87 -63.95 -16.14 -38.77 131.57 -1.48 Net Cash Inflow / Outflow -2.76 3.31 -6.54 8.05 -14.34 2.97 12.22 -51.48 49.66 -0.11 Opening Cash & Equivalents 14.86 10.92 17.47 9.42 23.76 20.80 8.58 60.06 10.40 10.47 Closing Cash & Equivalent 12.10 14.86 10.92 17.47 9.42 23.76 20.80 8.58 60.06 10.36

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 118.99 121.83 111.38 98.13 83.44 73.81 71.74 73.31 70.74 62.55 ROA -0.42% 6.29% 8.58% 10.60% 7.17% 1.97% -0.23% 3.42% 7.26% 9.21% ROE -0.79% 10.85% 14.64% 18.47% 12.75% 3.62% -0.43% 6.21% 12.61% 15.03% ROCE 2.84% 12.89% 17.42% 23.31% 15.59% 5.79% 1.24% 7.61% 11.84% 16.78% Fixed Asset Turnover 0.94 1.21 1.26 1.28 1.08 1.07 1.06 1.26 1.55 1.69 Receivable days 94.01 77.33 70.94 62.89 65.15 66.60 75.87 74.21 67.30 62.00 Inventory Days 80.93 64.86 69.70 64.99 65.63 64.62 71.02 66.28 58.30 56.43 Payable days 109.56 81.96 91.64 100.02 145.00 68.05 71.94 66.81 61.95 56.43 Cash Conversion Cycle 65.39 60.23 48.99 27.86 -14.22 63.17 74.95 73.68 63.66 62.01 Total Debt/Equity 0.67 0.44 0.31 0.27 0.34 0.38 0.45 0.42 0.43 0.24 Interest Cover 0.87 5.05 8.58 14.55 6.91 2.09 0.56 3.06 15.83 9.17

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 110.17 120.02 111.51 98.17 83.45 73.75 71.69 73.25 70.68 62.56 ROA -3.38% 4.98% 8.64% 10.63% 7.23% 1.96% -0.24% 3.42% 7.22% 9.15% ROE -7.34% 9.09% 14.72% 18.50% 12.85% 3.60% -0.43% 6.21% 12.55% 14.96% ROCE -0.43% 11.25% 17.50% 23.03% 15.67% 5.78% 1.23% 7.62% 11.80% 16.72% Fixed Asset Turnover 0.90 1.13 1.25 1.28 1.08 1.07 1.06 1.26 1.55 1.69 Receivable days 83.16 76.04 70.89 62.90 65.26 66.96 76.39 74.23 67.31 62.31 Inventory Days 84.67 68.19 69.62 64.95 65.58 64.61 71.01 66.40 58.84 57.17 Payable days 132.53 90.44 89.88 98.49 143.70 67.82 71.91 66.57 61.79 56.58 Cash Conversion Cycle 35.30 53.79 50.63 29.37 -12.86 63.74 75.49 74.06 64.37 62.91 Total Debt/Equity 0.96 0.59 0.31 0.27 0.34 0.39 0.45 0.42 0.43 0.24 Interest Cover -0.12 4.48 8.63 17.73 6.93 2.09 0.56 3.06 15.64 8.98

Top Investors:

nippon life india trustee ltd a/c nippon india small cap fund

quant mutual fund-quant small cap fund

dsp healthcare fund

franklin india small cap fund

hdfc value fund

mangeshi investment private limited

investor education and protection fund (iepf)

Annual Reports:

News Update:

Indoco Remedies gets EIR from USFDA for API manufacturing facility at Patalganga
12th Dec 2025, 12:17 PM

The inspection was conducted from September 15, 2025, to September 19, 2025.
Read More
Indoco Remedies - Quarterly Results
7th Nov 2025, 00:00 AM

Read More
USFDA completes inspection at Indoco Remedies’ API manufacturing facility
19th Sep 2025, 15:30 PM

The inspection concluded with zero form 483 observations
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback